LA JOLLA, CA, April 30, 2024 – Enlaza Therapeutics, the first covalent biologic platform company, today announced a $100 million Series A financing. The financing will be used to further...
Art Pappas will participate on a panel titled "Beyond Emerging Managers: Becoming an Established Manager" at the Emerging Managers 2009 Conference in Miami, FL
News | 04. 28. 2009
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.